Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease.
Olinger K, Liu X, Khoshpouri P, Khoshpouri P, Scoutt L, Khurana A, Chaubal R, Moshiri M. Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease. RadioGraphics 2024, 44: e230092. PMID: 38175802, DOI: 10.1148/rg.230092.Peer-Reviewed Original ResearchConceptsContrast-enhanced USFemale pelvisUS contrast agentEnd-stage renal diseaseContrast-enhanced CTExcellent safety profileModality of choiceUterine cavity morphologyVisualization of lesionsRenal diseaseGynecologic diseaseGynecologic tumorsPelvic diseaseSafety profileTubal patencyPelvic fistulasAdditional imagingIndeterminate lesionsContrast agentsDiseasePelvisImaging modalitiesExcellent optionLesionsCharacterization of disease